Toggle navigation
Home
Search
Services
Blog
Contact
About
Palladium Complexes Having IN-Vivo Antitumor Activity
Gill, Devinder
Andrulis Research Corporation, Bethesda, MD, United States
Search 7 grants from Devinder Gill
Search grants from Andrulis Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
Gastrointestinal Cancer Prevention and Care
Biochemistry and Molecular Biology of Protein Complexes
Regulation of protein kinase C and cell cycle by PAH o-quinones and ROS
Central Indiana STEM Talent Expansion Program
Recently added grants:
Behavioral and neural properties of spatial direction comprehension in aging and amestic mild cognitive impairment
Community Paramedicine Program to Improve Diabetes Management among Adults Experiencing Severe Hypoglycemia
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy
Examining the Stress Processes Relating Ethnicity and Sex to Substance Misuse and Services Outcomes (ESPRESSO)
The ontogeny and function of CD8 T cells in lung cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057819-000
Application #
3613434
Study Section
Project Start
1985-09-30
Project End
Budget Start
1985-09-30
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Andrulis Research Corporation
Department
Type
DUNS #
City
Bethesda
State
MD
Country
United States
Zip Code
20814
Related projects
NIH 1986
N43 CM
Palladium Complexes Having IN-Vivo Antitumor Activity
Gill, Devinder / Andrulis Research Corporation
NIH 1985
N43 CM
Palladium Complexes Having IN-Vivo Antitumor Activity
Gill, Devinder / Andrulis Research Corporation
Comments
Be the first to comment on Devinder Gill's grant